Skip to main content

Table 5 Primary Outcomes classified by Dimension and Domain: Multiple Efficacy Outcome Dataset

From: Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis

Dimension

Domain

Number (n/23)

Percentage (%)

Activity

All

20

87

 

AC cells

4

17

 

AC flare

2

9

 

Vitreous haze

2

9

 

Vitreous cells

1

4

 

Snowballs

1

4

 

Macular Oedema

7

30

 

Chorioretinal inflammatory lesions

2

9

 

Retinovascular inflammation

3

13

 

Treatment requirement

4

17

 

Unspecified ‘activity’

9

39

Damage/Other complications of disease

All

4

17

 

Elevated IOP

3

13

 

Cells on IOL

1

4

 

Posterior capsular opacification

1

4

Visual function (performance)

All

13

57

 

Visual acuity

13

57

Visual function (patient reported)

All

0

0

Unspecified

 

0

0